Please login to the form below

Not currently logged in
Email:
Password:

Lighting the way

How the UK’s Accelerated Access Review aims to guide medical innovations to their destination

Cell and gene therapies: on course for commercial success?

2016: The year when deal-makers took stock?

Merger-mania and asset swaps slowed and joint ventures were back in fashion

Deal Watch January 2017

Medius Deal WatchActelion, Johnson & Johnson, Sanofi, Takeda and more feature in this month's pharma deals round-up

Mining for results

How one tech firm is working with Big Data

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

Webinars

PC: Are you Patient Centric or just Politically Correct?

Everyone in pharma is talking about patient centricity, but how is the drive received ‘on the ground’ among patients who are its focus? How is it unfolding and how far

Communicating innovation to payers and policy makers

Involving public affairs early during the development and commercialisation process of a new asset is critical to success when demonstrating value to payers and policy makers.

Scale & Strategy: Essential tools for transforming the commercial model

Most life sciences companies know they need to move their multichannel marketing forward, but that requires managing a greater volume of tactics that need to be developed, approved, implemented, and

Immuno-oncology's evolution: implications for pharma market researche

Immuno-oncology therapies that harness the body’s own defences to fight tumours are widely acknowledged as the new frontier in cancer treatment, but until recently only a few products had reached

Country reports

The death of the cancer drugs fund?

UK flagNHS England's siloed budget and its uncertain future

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

Video

Webinar: Customer engagement design

Customer engagement design pharma Webinar: Customer engagement design

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

The impact of new technology on healthcare

Mindy Daeschner PSHealth PMLiVE speaks to Mindy Daeschner, director of healthcare technology company PSHealth.

White papers

The future of medical content: The personal touch

The purpose of delivering personalised content to HCPs is not just about customer experience, it's about improving healthcare. Our Commercial Director, Tib Catania discusses what ‘deep learning’ means for the

Rise of the patient expert - an interview with Michael Seres

Founded by Michael Seres in 2011, 11 Health is a connected medical device company currently working to change the lives of patients using stoma bags. Content Marketing Manager Liz Inskip

Making sense of Nutraceuticals in China

Published in eyeforpharma February 2017 by Marc Yates

Research Partnership has been ranked in the Pharma Times Pharma Fast 50

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

We are GCI Health, one of the world’s largest specialist health and medical communications agencies with global hubs in London...

Infographics